newsfilter
← Latest News
PR Newswire·

Lakewood-Amedex Biotherapeutics to Present at Life Sciences Virtual Investor Forum

  • Lakewood-Amedex Biotherapeutics Inc. (NASDAQ: LABT) announced that CEO Kelvin Cooper, Ph.D., will present at the Life Sciences Virtual Investor Forum.
  • The presentation is scheduled for June 25, 2026, at 11:30 AM EDT.
  • The company will discuss its growth strategy & the potential of Nu-3, a topical gel for treating infected diabetic foot ulcers (iDFU).
  • Nu-3 is advancing into Phase 2 clinical trials to address mild iDFU cases that can lead to amputations.
  • Lakewood-Amedex develops the Bisphosphocin® class of fast-acting, broad-spectrum antimicrobials to combat antibiotic-resistant strains like MRSA & VRE.
  • The press release includes forward-looking statements regarding clinical plans, regulatory strategies, & potential benefits subject to risks & uncertainties.